{"result": "(\"entity\"<|>AMERICAN THORACIC SOCIETY<|>ORGANIZATION<|>The American Thoracic Society is a professional organization focused on advancing the clinical and scientific understanding of respiratory diseases, including chronic obstructive pulmonary disease (COPD).)\n##\n(\"entity\"<|>EUROPEAN RESPIRATORY SOCIETY<|>ORGANIZATION<|>The European Respiratory Society is a professional organization dedicated to promoting lung health and advancing research in respiratory medicine, including COPD.)\n##\n(\"entity\"<|>CHRONIC OBSTRUCTIVE PULMONARY DISEASE<|>EVENT<|>Chronic Obstructive Pulmonary Disease (COPD) is a progressive lung disease characterized by increasing breathlessness, often caused by long-term exposure to irritating gases or particulate matter, most often from cigarette smoke.)\n##\n(\"entity\"<|>CYSTIC FIBROSIS<|>EVENT<|>Cystic Fibrosis is a genetic disorder that affects the lungs and digestive system, leading to severe respiratory and nutritional challenges.)\n##\n(\"entity\"<|>BRONCHIECTASIS<|>EVENT<|>Bronchiectasis is a condition characterized by the abnormal and permanent dilation of the bronchi, leading to chronic respiratory infections and inflammation.)\n##\n(\"entity\"<|>NUTRITIONAL DEPLETION<|>EVENT<|>Nutritional depletion refers to a state where an individual lacks essential nutrients, which can significantly impact health, particularly in patients with chronic diseases like COPD.)\n##\n(\"entity\"<|>METABOLIC SYNDROME<|>EVENT<|>Metabolic syndrome is a cluster of conditions that increase the risk of heart disease, stroke, and diabetes, often associated with obesity and insulin resistance.)\n##\n(\"entity\"<|>OSTEOPENIA<|>EVENT<|>Osteopenia is a condition characterized by lower than normal bone density, which can lead to osteoporosis and increased fracture risk, particularly in patients with chronic diseases.)\n##\n(\"entity\"<|>OSTEOPOROSIS<|>EVENT<|>Osteoporosis is a medical condition in which the bones become weak and brittle, increasing the risk of fractures, often seen in patients with chronic respiratory diseases.)\n##\n(\"entity\"<|>NUTRITION CARE GUIDELINES<|>EVENT<|>Nutrition care guidelines provide recommendations for dietary management and nutritional support for individuals with specific health conditions, including cystic fibrosis.)\n##\n(\"relationship\"<|>AMERICAN THORACIC SOCIETY<|>EUROPEAN RESPIRATORY SOCIETY<|>Both organizations collaborate on advancing research and clinical practices related to respiratory diseases, including COPD<|>7)\n##\n(\"relationship\"<|>CHRONIC OBSTRUCTIVE PULMONARY DISEASE<|>NUTRITIONAL DEPLETION<|>Nutritional depletion is a common issue faced by patients with chronic obstructive pulmonary disease, impacting their overall health and recovery<|>8)\n##\n(\"relationship\"<|>CHRONIC OBSTRUCTIVE PULMONARY DISEASE<|>OSTEOPENIA<|>Patients with chronic obstructive pulmonary disease are at increased risk for osteopenia due to factors like inactivity and nutritional deficiencies<|>6)\n##\n(\"relationship\"<|>CHRONIC OBSTRUCTIVE PULMONARY DISEASE<|>OSTEOPOROSIS<|>Chronic obstructive pulmonary disease can lead to osteoporosis, increasing the risk of fractures in affected individuals<|>6)\n##\n(\"relationship\"<|>CYSTIC FIBROSIS<|>NUTRITION CARE GUIDELINES<|>Nutrition care guidelines are essential for managing the dietary needs of patients with cystic fibrosis to ensure proper growth and health<|>9)\n##\n(\"relationship\"<|>BRONCHIECTASIS<|>NUTRITIONAL DEPLETION<|>Nutritional depletion is often observed in patients with bronchiectasis due to chronic infections and inflammation<|>7)\n##\n(\"relationship\"<|>METABOLIC SYNDROME<|>CHRONIC OBSTRUCTIVE PULMONARY DISEASE<|>There is a significant association between metabolic syndrome and chronic obstructive pulmonary disease, impacting patient management<|>5)\n<|COMPLETE|>", "input": "\n-Goal-\nGiven a text document that is potentially relevant to this activity and a list of entity types, identify all entities of those types from the text and all relationships among the identified entities.\n \n-Steps-\n1. Identify all entities. For each identified entity, extract the following information:\n- entity_name: Name of the entity, capitalized\n- entity_type: One of the following types: [organization,person,geo,event]\n- entity_description: Comprehensive description of the entity's attributes and activities\nFormat each entity as (\"entity\"<|><entity_name><|><entity_type><|><entity_description>)\n \n2. From the entities identified in step 1, identify all pairs of (source_entity, target_entity) that are *clearly related* to each other.\nFor each pair of related entities, extract the following information:\n- source_entity: name of the source entity, as identified in step 1\n- target_entity: name of the target entity, as identified in step 1\n- relationship_description: explanation as to why you think the source entity and the target entity are related to each other\n- relationship_strength: a numeric score indicating strength of the relationship between the source entity and target entity\n Format each relationship as (\"relationship\"<|><source_entity><|><target_entity><|><relationship_description><|><relationship_strength>)\n \n3. Return output in English as a single list of all the entities and relationships identified in steps 1 and 2. Use **##** as the list delimiter.\n \n4. When finished, output <|COMPLETE|>\n \n######################\n-Examples-\n######################\nExample 1:\nEntity_types: ORGANIZATION,PERSON\nText:\nThe Verdantis's Central Institution is scheduled to meet on Monday and Thursday, with the institution planning to release its latest policy decision on Thursday at 1:30 p.m. PDT, followed by a press conference where Central Institution Chair Martin Smith will take questions. Investors expect the Market Strategy Committee to hold its benchmark interest rate steady in a range of 3.5%-3.75%.\n######################\nOutput:\n(\"entity\"<|>CENTRAL INSTITUTION<|>ORGANIZATION<|>The Central Institution is the Federal Reserve of Verdantis, which is setting interest rates on Monday and Thursday)\n##\n(\"entity\"<|>MARTIN SMITH<|>PERSON<|>Martin Smith is the chair of the Central Institution)\n##\n(\"entity\"<|>MARKET STRATEGY COMMITTEE<|>ORGANIZATION<|>The Central Institution committee makes key decisions about interest rates and the growth of Verdantis's money supply)\n##\n(\"relationship\"<|>MARTIN SMITH<|>CENTRAL INSTITUTION<|>Martin Smith is the Chair of the Central Institution and will answer questions at a press conference<|>9)\n<|COMPLETE|>\n\n######################\nExample 2:\nEntity_types: ORGANIZATION\nText:\nTechGlobal's (TG) stock skyrocketed in its opening day on the Global Exchange Thursday. But IPO experts warn that the semiconductor corporation's debut on the public markets isn't indicative of how other newly listed companies may perform.\n\nTechGlobal, a formerly public company, was taken private by Vision Holdings in 2014. The well-established chip designer says it powers 85% of premium smartphones.\n######################\nOutput:\n(\"entity\"<|>TECHGLOBAL<|>ORGANIZATION<|>TechGlobal is a stock now listed on the Global Exchange which powers 85% of premium smartphones)\n##\n(\"entity\"<|>VISION HOLDINGS<|>ORGANIZATION<|>Vision Holdings is a firm that previously owned TechGlobal)\n##\n(\"relationship\"<|>TECHGLOBAL<|>VISION HOLDINGS<|>Vision Holdings formerly owned TechGlobal from 2014 until present<|>5)\n<|COMPLETE|>\n\n######################\nExample 3:\nEntity_types: ORGANIZATION,GEO,PERSON\nText:\nFive Aurelians jailed for 8 years in Firuzabad and widely regarded as hostages are on their way home to Aurelia.\n\nThe swap orchestrated by Quintara was finalized when $8bn of Firuzi funds were transferred to financial institutions in Krohaara, the capital of Quintara.\n\nThe exchange initiated in Firuzabad's capital, Tiruzia, led to the four men and one woman, who are also Firuzi nationals, boarding a chartered flight to Krohaara.\n\nThey were welcomed by senior Aurelian officials and are now on their way to Aurelia's capital, Cashion.\n\nThe Aurelians include 39-year-old businessman Samuel Namara, who has been held in Tiruzia's Alhamia Prison, as well as journalist Durke Bataglani, 59, and environmentalist Meggie Tazbah, 53, who also holds Bratinas nationality.\n######################\nOutput:\n(\"entity\"<|>FIRUZABAD<|>GEO<|>Firuzabad held Aurelians as hostages)\n##\n(\"entity\"<|>AURELIA<|>GEO<|>Country seeking to release hostages)\n##\n(\"entity\"<|>QUINTARA<|>GEO<|>Country that negotiated a swap of money in exchange for hostages)\n##\n##\n(\"entity\"<|>TIRUZIA<|>GEO<|>Capital of Firuzabad where the Aurelians were being held)\n##\n(\"entity\"<|>KROHAARA<|>GEO<|>Capital city in Quintara)\n##\n(\"entity\"<|>CASHION<|>GEO<|>Capital city in Aurelia)\n##\n(\"entity\"<|>SAMUEL NAMARA<|>PERSON<|>Aurelian who spent time in Tiruzia's Alhamia Prison)\n##\n(\"entity\"<|>ALHAMIA PRISON<|>GEO<|>Prison in Tiruzia)\n##\n(\"entity\"<|>DURKE BATAGLANI<|>PERSON<|>Aurelian journalist who was held hostage)\n##\n(\"entity\"<|>MEGGIE TAZBAH<|>PERSON<|>Bratinas national and environmentalist who was held hostage)\n##\n(\"relationship\"<|>FIRUZABAD<|>AURELIA<|>Firuzabad negotiated a hostage exchange with Aurelia<|>2)\n##\n(\"relationship\"<|>QUINTARA<|>AURELIA<|>Quintara brokered the hostage exchange between Firuzabad and Aurelia<|>2)\n##\n(\"relationship\"<|>QUINTARA<|>FIRUZABAD<|>Quintara brokered the hostage exchange between Firuzabad and Aurelia<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>ALHAMIA PRISON<|>Samuel Namara was a prisoner at Alhamia prison<|>8)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>MEGGIE TAZBAH<|>Samuel Namara and Meggie Tazbah were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>DURKE BATAGLANI<|>Samuel Namara and Durke Bataglani were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>MEGGIE TAZBAH<|>DURKE BATAGLANI<|>Meggie Tazbah and Durke Bataglani were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>FIRUZABAD<|>Samuel Namara was a hostage in Firuzabad<|>2)\n##\n(\"relationship\"<|>MEGGIE TAZBAH<|>FIRUZABAD<|>Meggie Tazbah was a hostage in Firuzabad<|>2)\n##\n(\"relationship\"<|>DURKE BATAGLANI<|>FIRUZABAD<|>Durke Bataglani was a hostage in Firuzabad<|>2)\n<|COMPLETE|>\n\n######################\n-Real Data-\n######################\nEntity_types: organization,person,geo,event\nText: .gov/pubmed/25234804.\n\n38. Schols AMWJ, Broekhuizen R, Weling-Scheepers CA, Wouters EF. Body composition and mortality in chronic obstructive pulmonary disease. Am J Clin Nutr 2005; 82:53–9. Available from: http://www.ncbi.nlm.nih.gov/pubmed/16002800.\n\n39. Celli BR, Cote CG, Marin JM, Casanova C, Montes de Oca M, Mendez RA, et al. The Body-Mass Index, Airflow Obstruction, Dyspnea, and Exercise Capacity Index in Chronic Obstructive Pulmonary Disease. N Engl J Med 2004; 350:1005–12. Available from: http://www.ncbi.nlm.nih.gov/pubmed/14999112.\n\n40. Vermeeren MAP, Creutzberg EC, Schols AMWJ, Postma DS, Pieters WR, Roldaan AC, et al. Prevalence of nutritional depletion in a large out-patient population of patients with COPD. Respir Med 2006; 100:1349–55. Available from: http://linkinghub.elsevier.com/retrieve/pii/S0954611105005135.\n\n41. Bolton CE, Ionescu AA, Shiels KM, Pettit RJ, Edwards PH, Stone MD, et al. Associated Loss of Fat-free Mass and Bone Mineral Density in Chronic Obstructive Pulmonary Disease. Am J Respir Crit Care Med 2004; 170:1286–93. Available from: http://www.ncbi.nlm.nih.gov/pubmed/15374843.\n\n42. Soler-Cataluña JJ, Sánchez-Sánchez L, Martínez-García MA, Sánchez PR, Salcedo E, Navarro M. Mid-arm muscle area is a better predictor of mortality than body mass index in COPD. Chest 2005; 128:2108–15.\n\n43. Vilaró J, Ramirez-Sarmiento A, Martínez-Llorens JM, Mendoza T, Alvarez M, Sánchez-Cayado N, et al. Global muscle dysfunction as a risk factor of readmission to hospital due to COPD exacerbations. Respir Med 2010; 104:1896–902. Available from: http://www.ncbi.nlm.nih.gov/pubmed/20541383.\n\n44. Onen ZP, Gulbay BE, Sen E, Yildiz OA, Saryal S, Acican T, et al. Analysis of the factors related to mortality in patients with bronchiectasis. Respir Med 2007; 101:1390–7. Available from: http://www.ncbi.nlm.nih.gov/pubmed/17374480.\n\n45. Maiz L, Giron R, Olveira C, Vendrell M, Nieto R, Martinez-Garcia MA. Prevalence and factors associated with nontuberculous mycobacteria in non-cystic fibrosis bronchiectasis: a multicenter observational study. BMC Infect Dis 2016; 16:437.\n\n46. Olveira G, Olveira C, Gaspar I, Porras N, Martín-Núñez G, Rubio E, et al. Fat-free mass depletion and inflammation in patients with bronchiectasis. J Acad Nutr Diet 2012; 112:1999–2006. Available from: http://www.ncbi.nlm.nih.gov/pubmed/23174686.\n\n47. Olveira G, Olveira C, Dorado A, García-Fuentes E, Rubio E, Tinahones F, et al. Cellular and plasma oxidative stress biomarkers are raised in adults with bronchiectasis. Clin Nutr 2013; 32:112–7. Available from: http://www.ncbi.nlm.nih.gov/pubmed/22749311.\n\n48. Spruit MA, Singh SJ, Garvey C, ZuWallack R, Nici L, Rochester C, et al. An official American Thoracic Society/European Respiratory Society statement: key concepts and advances in pulmonary rehabilitation. Am J Respir Crit Care Med 2013; 188:e13-64.\n\n49. Cebron Lipovec N, Beijers RJHCG, van den Borst B, Doehner W, Lainscak M, Schols AMWJ. The Prevalence of Metabolic Syndrome In Chronic Obstructive Pulmonary Disease: A Systematic Review. COPD J Chronic Obstr Pulm Dis 2016; 13:399–406. Available from: http://www.ncbi.nlm.nih.gov/pubmed/26914392.\n\n50. Diehl N, Johnson MM. Prevalence of Osteopenia and Osteoporosis in Patients with Noncystic Fibrosis Bronchiectasis. South Med J 2016; 109:779–83. Available from: http://www.ncbi.nlm.nih.gov/pubmed/27911973.\n\n51. Graat-Verboom L, Wouters EFM, Smeenk FWJM, van den Borne BEEM, Lunde R, Spruit MA. Current status of research on osteoporosis in COPD: a systematic review. Eur Respir J 2009; 34:209–18. Available from: http://www.ncbi.nlm.nih.gov/pubmed/19567604.\n\n52. Turck D, Braegger CP, Colombo C, Declercq D, Morton A, Pancheva R, et al. ESPEN-ESPGHAN-ECFS guidelines on nutrition care for infants, children, and adults with cystic fibrosis. Clin Nutr 2016; 35:557–77. Available from:\n######################\nOutput:", "parameters": {"model": "gpt-4o-mini", "temperature": 0.0, "frequency_penalty": 0.0, "presence_penalty": 0.0, "top_p": 1.0, "max_tokens": 4000, "n": 1}, "history": null}